Actualités - BIOQuébec

12 May 2025
Zynext Ventures invests in Feldan Thérapeutiques to accelerate innovation in intracellular drug delivery
Feldan Therapeutics announces an investment from Zynext Ventures, the venture capital arm of Zydus Lifesciences...
Read More
8 May 2025
Researchers & industry professionals: help shape Quebec’s RNA ecosystem
CQDM is conducting a strategic survey to evaluate the RNA mobilizing project, a government initiative aimed at...
Read More
8 May 2025
Zilia Closes Bridge Round with Participation from Existing and New Investors Including Linearis Ventures
Zilia Inc. (''Zilia''), a medical technology company pioneering the use of the eye as a window into systemic health...
Read More
8 May 2025
Precision medicine on the front line: what concrete impact on care ?
Les avancées en génomique et en médecine de précision commencent à trouver leur place dans les soins primaires. Mais quels…
Read More
8 May 2025
PQE Group US Earns Great Place to Work Certification™
For its fourth consecutive year, the company is recognized with this certification...
Read More
6 May 2025
Temporary duty exemption on U.S. imports - Public health and healthcare
BIOQuébec informs its members that an exemption from Canadian surtaxes on certain U.S. goods is in effect until October 15, 2025...
Read More

diaMentis selected by Dassault Systèmes to join an exclusive group of innovative companies in the 3DEXPERIENCE Lab accelerator program

diaMentis, a company developing an innovative diagnostic support technology in mental health, recognized by...